ArticleJournal of translational medicine2020

WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target.

Bin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.